Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cipla Ltd. Regulatory Filings 2022

Feb 10, 2022

59275_rns_2022-02-10_1b36c7f0-4efc-4277-b97a-08dea06f5125.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [84 x 30] intentionally omitted <==

10[th] February 2022

(1) BSE Limited (2) National Stock Exchange of India Limited Listing Department, Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 Scrip Code: 500087 Scrip Code: CIPLA EQ

  • (3) SOCIETE DE LA BOURSE DE LUXEMBOURG

Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Dear Sir/Madam,

Sub: De-registration of Wholly Owned Step-Down Subsidiary

This is to inform you that in terms of de-registration notice issued by the Companies and Intellectual Property Commission, Republic of South Africa on 9[th] February 2022, Cipla Biotec South Africa (Pty) Limited (“Cipla Biotec SA”), wholly owned step-down subsidiary of the Company, has been de-registered with effect from 3[rd] February 2022.

Cipla Biotec SA was a dormant entity and this de-registration will not affect performance or revenue of the Company.

This is for your information and records.

Thanking you

Yours faithfully,

For Cipla Limited

RAJENDR Digitally signed by RAJENDRA A KUMAR KUMAR CHOPRA Date: 2022.02.10 CHOPRA 17:28:13 +05'30'

Rajendra Chopra Company Secretary

Prepared by: Simona Dsouza

Cipla Ltd. Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India P +91 22 24826000 F +91 22 24826120 W www.cipla.com E-mail [email protected] Corporate Identity Numbe r L24239MH1935PLC002380